Upcoming PharmaMar dividend
Change(%)
0.00%
No change
Next payment 0.65€
Next payment date Jun 14, 2024
Last payment 0.65€
Last payment date Jun 9, 2023
00 D 00 H 00 M 00 S
Ex-Dividend: 6/12/24
Confirmed

June 14, 2024 has been set as the date when PharmaMar will make the dividend payment, corresponding to 0,65 euros per share.

June 12, 2024 marks the final date to buy shares of PharmaMar if you wish to receive a dividend on June 14, 2024.

PharmaMar (PHM) granted a dividend of 0.65 euros on June 9, 2023.

PharmaMar, which trades under the symbol PHMR, pays dividends to its shareholders every year, although it has been reported that part of its Board of Directors has proposed using this budget item for research and development.

It is a share with a general downward trend, although quite stable and with ample growth possibilities, with a dividend yield of approximately 1.8%, with payments being made once a year between April, May, June or July.

Payout Ratio PharmaMar Dividends

PharmaMar paid 57% of its net income in the last fiscal period as dividends.
PharmaMar's earnings (162,140,000.00€) are sufficient to cover the dividend payment. This payment represents 57% of the total net profit of PHM.
Dividend payout ratio
Payout Ratio

Dividend calendar of PharmaMar

These are the most important events of the PharmaMar calendar in 2024:

Event Day
Last trading date June 11, 2024
Ex-Dividend (Ex-Date) June 12, 2024
Record date June 13, 2024
Date of payment June 14, 2024
Data confirmed by the company PharmaMar (PHM).
Confirmed
Source
Historical annual dividend yields of PharmaMar
Over the past 5 years, PharmaMar has not consistently distributed dividends.
Increasing Dividends
Dividend yield
Dividend yield of PharmaMar vs. the sector
PharmaMar's dividend yield (1.93%) is above the sector average (1.77%).
Comparison with industry average
PharmaMar's dividend yield is between the top 25% (2.24%) and top 75% (1.11%) of the sector.
Evaluation with respect to competence.
Dividend yield history in PharmaMar
Over the past 5 years, PharmaMar has not consistently distributed dividends.
Dividend stability

Dividend history of PharmaMar

In this table you can see the complete history:

YearEx-DividendAmountTotal
2023
06/07/2023
0.65 €
0.65 €
2022
07/13/2022
0.65 €
0.65 €
2021
04/28/2021
0.6 €
0.6 €
2020
06/26/2020
0.480002 €
0.480002 €
PharmaMar dividend capture strategy
Step 1: Buy PharmaMar shares (PHM) one day before ex-dividend date
Date of purchase Jun 11, 2024
Next ex-dividend date Jun 12, 2024
Step 2: Sell PharmaMar shares (PHM) when the price recovers.
Date of sale (estimated) Jun 14, 2024
Average price recovery 3 days
Average return on cost 0.96%
The dividend capture strategy is based on historical PharmaMar data. Past performance is no guarantee of future results.

Information about PharmaMar

Full name Pharma Mar, S.A.
Ticker PHM
Sector Health Care
Industry Biotechnology
Market Capitalization 602.20 €
Number of Employees 509
Description of the company

PharmaMar is a Spanish company engaged in the pharmaceutical industry, specializing in research, development, creation and marketing of drugs made from marine resources, mainly to treat some types of cancer and mental illnesses such as Alzheimer's disease.

It was founded in 1986, although its beginnings came from Zeltia, which focused on the manufacture of drugs to prevent gynecological, cardiovascular, metabolic and hormonal diseases; it diversified in 1949 when it joined other laboratories and began to produce and package antibiotics, but it was not until 1986 that José María Fernández Sousa established the subsidiary PharmaMar.

Its creation was based on the understanding that most drugs are made from terrestrial components, shrubs, fungi, bacteria, among others.

Its main products include "Yondelis" trabectedin used to treat sarcoma and ovarian cancer, "Zepzelca" lurbinectedin recommended for lung cancer and "Aplidin" plitidepsin recommended for the treatment of multiple myeloma, as well as the commercialization of a rapid diagnostic kit for COVID-19 through its subsidiary Genomica.

Frequently asked questions about PharmaMar dividends

PharmaMar is listed on the Madrid Stock Exchange and is part of the Ibex Medium.

PharmaMar has the Ticker or stock code PHM.

The CEO of PharmaMar in 2024 is Mr. Jose Maria Fernandez Sousa-Faro Ph.D..

PharmaMar ForumCheck the latest comments and participate in the live chat on PharmaMar stocks (PHM).
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments